Globus Medical, Inc.

Globus Medical Inc Class A's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Globus Medical Inc Class A has 134.25M shares outstanding.

As of June 30, 2026, Globus Medical Inc Class A maintains a current ratio of 4.62, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Globus Medical Inc Class A posted a return on equity (ROE) of 11.81, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.16 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.52, useful for judging operating efficiency across full business cycles. The company generates approximately 472,576.95 in revenue per employee across its workforce of 5,825.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.25 indicates how many times Globus Medical Inc Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Globus Medical Inc Class A recorded 109.14M in income tax expense. That works out to an effective tax rate of 18.89, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 577.80M, leaving 468.66M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Globus Medical Inc Class A generated 2.75B in revenue and converted that into 468.66M in net income, yielding earnings per share of 3.42. EBITDA reached 804.78M, while operating income came in at 589.75M.

As of June 30, 2026, Globus Medical Inc Class A holds 520.93M in cash and equivalents against 97.33M in total debt, resulting in a net debt position of -444.43M. Total book value stands at 4.17B, with working capital of 1.52B providing operational flexibility.

Globus Medical Inc Class A produced 796.86M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -139.65M in capital expenditures, free cash flow totaled 657.21M - equivalent to 4.87 per share.

Over the twelve months ended June 30, 2026, Globus Medical Inc Class A posted a gross margin of 68.55, reflecting its pricing power and cost economics. The operating margin of 21.42 and net profit margin of 17.03 provide insight into operational efficiency.